Joseph Clay Thornton, Interim CFO of Clover Health Investments, Corp. /DE (NASDAQ:CLOV), filed a Form 4 on August 13, 2026, disclosing the acquisition of 54,347 shares of Class A Common Stock through a time-based restricted stock unit award dated August 12, 2026.
A Form 4 filed on August 13, 2026 discloses that Noel B. Geer, a director of Leidos Holdings, Inc. (NYSE:LDOS), sold a total of 10,000 shares of common stock on August 11, 2026 in two separate open-market transactions.
A Form 4 filed on August 13, 2026 discloses that Narinder Singh, a director of PAR Technology Corp (NYSE:PAR), purchased common stock on August 12, 2026.
Jonathan M. Del Nero, Vice President and Controller of Hubbell Incorporated (NYSE:HUBB), filed a Form 4 on August 13, 2026, disclosing the sale of 547 shares of common stock on August 11, 2026.
A Form 4 filed on August 13, 2026, with the SEC discloses that Mary Ann Tighe, a director of Howard Hughes Holdings Inc. (NYSE:HHH), reported a sale of 13,495 shares of common stock on August 11, 2026, transacted indirectly through her husband.
Robert M. Lightfoot Jr., President Space at Lockheed Martin Corp (NYSE:LMT), filed a Form 4 on August 13, 2026, reporting the sale of common stock across two trading days in August 2026.
Stephen J. McAnena, President and CEO of Kemper Corp, filed a Form 4 on August 13, 2026, reporting the open-market purchase of 3,000 shares of Kemper Corp common stock on that same date.
Pharvaris N.V. President Lu Peng filed a Form 4 on August 13, 2026, disclosing two share dispositions on August 11 and August 12, 2026, both representing shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.
David A. Dykstra, Vice Chairman and COO of Wintrust Financial Corp, filed a Form 4 on August 13, 2026, disclosing the sale of 13,515 shares of common stock on that same date.
Jerome Benedict Durso, President and CEO of Altimmune, Inc. (NASDAQ:ALT), filed a Form 4 on August 13, 2026, reporting the open-market purchase of 15,000 shares of Altimmune common stock on that same date.